7-[2-Deoxy-alpha-L-fucopyranosyl-(1->4)-3-amino-2,3-dideoxy-alpha-L-fucopyranoside]-doxorubicinone

ID: ALA4796372

PubChem CID: 162676304

Max Phase: Preclinical

Molecular Formula: C33H39NO14

Molecular Weight: 673.67

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@H]2C[C@H](O)[C@H](O)[C@H](C)O2)[C@H](C)O1

Standard InChI:  InChI=1S/C33H39NO14/c1-12-27(38)17(36)8-22(45-12)48-32-13(2)46-21(7-16(32)34)47-19-10-33(43,20(37)11-35)9-15-24(19)31(42)26-25(29(15)40)28(39)14-5-4-6-18(44-3)23(14)30(26)41/h4-6,12-13,16-17,19,21-22,27,32,35-36,38,40,42-43H,7-11,34H2,1-3H3/t12-,13-,16-,17-,19-,21-,22-,27+,32+,33-/m0/s1

Standard InChI Key:  DDKNKONQTRIQSW-IEALUYQASA-N

Molfile:  

 
     RDKit          2D

 50 55  0  0  0  0  0  0  0  0999 V2000
   28.3376   -3.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3252   -4.3088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6153   -4.7174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6153   -3.0624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7573   -4.3088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7573   -3.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9013   -4.3088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0474   -3.0748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0351   -4.7174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9054   -3.4751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1853   -3.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4589   -4.7298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4631   -3.0748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1069   -5.9886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3764   -6.3559    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.1812   -4.3212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7962   -6.4220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0203   -7.6189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7549   -7.2433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3393   -7.1690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1482   -5.1673    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.6153   -2.2493    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.6153   -5.5387    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.1914   -4.7174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0474   -2.2617    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.0351   -5.5387    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.8828   -3.8961    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.4400   -7.6932    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.9749   -8.4402    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.1914   -3.0748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1914   -5.5387    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.6046   -7.5446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4856   -3.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4733   -4.3088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4733   -5.9391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7573   -5.1301    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   31.7632   -2.9056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5532   -3.1143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5488   -2.1170    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.1290   -2.5344    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.2457   -8.8091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5641   -8.3596    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.8373   -8.7252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7879   -9.5412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4717   -9.9904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2049   -9.6236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1549   -8.2756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0573   -9.9074    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.4238  -10.8062    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.2402   -7.9903    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  1  1  0
  5  6  1  0
  6  8  2  0
  7 10  1  0
  8  1  1  0
  9  2  1  0
 10  4  1  0
 11 13  1  0
 12  5  1  0
 13  6  1  0
 14 21  1  1
 15 14  1  0
 16 11  1  0
 17 14  1  0
 18 19  1  0
 19 17  1  0
 20 15  1  0
 21 12  1  0
 22  4  2  0
 23  3  2  0
 24  7  2  0
 25  8  1  0
 26  9  1  0
 11 27  1  6
 19 28  1  6
 18 29  1  6
 30 10  2  0
 31 24  1  0
 20 32  1  6
 33 30  1  0
 34 33  2  0
 35 31  1  0
 12 36  1  1
  5  9  2  0
  7  3  1  0
 16 12  1  0
 24 34  1  0
 18 20  1  0
 11 37  1  0
 37 38  1  0
 37 39  2  0
 38 40  1  0
 29 41  1  0
 41 42  1  0
 41 46  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
 43 47  1  6
 44 48  1  6
 45 49  1  6
 41 50  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4796372

    ---

Associated Targets(Human)

DNA (187 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MEL-JUSO (130 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-87 MG (3946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2A Tclin DNA topoisomerase II alpha (6317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 673.67Molecular Weight (Monoisotopic): 673.2371AlogP: -0.12#Rotatable Bonds: 7
Polar Surface Area: 244.76Molecular Species: BASEHBA: 15HBD: 7
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.99CX Basic pKa: 9.01CX LogP: 0.68CX LogD: 0.31
Aromatic Rings: 2Heavy Atoms: 48QED Weighted: 0.16Np Likeness Score: 1.73

References

1. Wander DPA,van der Zanden SY,van der Marel GA,Overkleeft HS,Neefjes J,Codée JDC.  (2020)  Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents.,  63  (21): [PMID:33064004] [10.1021/acs.jmedchem.0c01191]

Source